Loading…
99,167 grants found
Showing 1,181 – 1,200 of 99,167 grants
ABSTRACT This application proposes to adapt a Formerly Incarcerated Transitions (FIT) program for mostly African American women, often with health disparities, who are released fro...
PROJECT SUMMARY Chronic pain is a global healthcare problem that reduces the quality of patients’ lives and increases med- ical expenditures. Inadequate pain control with available...
Project Summary Patients with advanced acral melanoma (AM) suffer worse outcomes relative to patients with cutaneous melanoma (CM), in part, because they do not respond as well to...
SUMMARY The objective of this proposal is to investigate how temporal lobe (TL) seizures with different onset patterns propagate through the basal ganglia (BG) and to evaluate the...
SUMMARY. The Vaccines and Therapeutic Antibodies to Respirovirus, Rubulavirus, Peribunyavirus and Phenuivirus (R2P2) ReVAMPP Center will utilize both well-defined and novel approac...
ABSTRACT – Core A: Administrative Core The Administrative Core A of the Vaccines and Therapeutic Antibodies to Respirovirus, Rubulavirus, Peribunyavirus and Phenuivirus (R2P2) ReVA...
ABSTRACT Core B: Data Management Core Washington University (Miller, J. Philip) The overarching objective of the Data Management Core-B is to serve as the central hub for the analy...
PROJECT SUMMARY - Core C: Structure Core Structure-based vaccine antigen design is a key component of the prototype pathogen approach to pandemic preparedness. For each prototype p...
ABSTRACT Core D: Antibody Core Washington University (Ellebedy, Ali) Respiroviruses, Rubulaviruses, Peribunyaviruses, and Phenuiviruses present major health burdens and have pandem...
ABSTRACT Core E: Immunogenicity and Immune Correlates Core (Correlates) The goal of Core E-Correlates will be to provide support to the projects by conducting various technical mea...
Human parainfluenza virus type 3 (HPIV3) is the P1-Respiroviruses prototype for advancement of vaccines and therapeutic antibodies against respiroviruses due to the advanced state...
Project 2: Abstract Rubulaviruses are respiratory pathogens with a high level of transmissibility (R0 = 4-7). MuV is an ideal prototype pathogen to study paramyxoviruses because we...
SUMMARY. The long term goals of Project 3 of the Respiro, Rubula, Peribunya, Phenui (R2P2) ReVAMPP are to use a prototype pathogen approach to identify and validate generalizable v...
PROJECT SUMMARY/ABSTRACT Prototype pathogens are those that, if well-characterized, can be used to develop generalizable medical countermeasures (MCMs) against new or unknown but r...
CORE A: SUMMARY/ABSTRACT This Program Project comprises four individual projects, which will: extend the WISDOM Study to evaluate the use of subtype-specific risk models and associ...
Project 4 will evaluate the benefits, harms, and costs of personalized screening using one of the CISNET models of breast cancer. We will evaluate the current approaches to persona...
CORE B: SUMMARY/ABSTRACT The Biostatistics and Bioinformatics Core’s primary goal is to collaborate with the P01 Investigators and other Core resource scientists to ensure that res...
CORE C: SUMMARY/ABSTRACT A polygenic risk score (PRS) combines risk information from many common genetic variants associated with a disease to predict the risk of that disease. PRS...
Euchromatic histone methyltransferase 1 (EHMT1, also known as GLP) is a key histone methylation writer intricately associated with Kleefstra Syndrome (KS), a multifaceted neurodeve...
ABSTRACT: Down syndrome (DS), the chromosomal disorder caused by trisomy of chromosome 21 (Tri21), presents many neurological conditions, including intellectual disability (ID), au...